Cargando…
Elevated Expression of Phospholipid Transfer Protein in Bone Marrow Derived Cells Causes Atherosclerosis
BACKGROUND: Phospholipid transfer protein (PLTP) is expressed by various cell types. In plasma, it is associated with high density lipoproteins (HDL). Elevated levels of PLTP in transgenic mice result in decreased HDL and increased atherosclerosis. PLTP is present in human atherosclerotic lesions, w...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2386265/ https://www.ncbi.nlm.nih.gov/pubmed/18509527 http://dx.doi.org/10.1371/journal.pone.0002255 |
_version_ | 1782155226031063040 |
---|---|
author | van Haperen, Rien Samyn, Hannelore Moerland, Matthijs van Gent, Teus Peeters, Marian Grosveld, Frank van Tol, Arie de Crom, Rini |
author_facet | van Haperen, Rien Samyn, Hannelore Moerland, Matthijs van Gent, Teus Peeters, Marian Grosveld, Frank van Tol, Arie de Crom, Rini |
author_sort | van Haperen, Rien |
collection | PubMed |
description | BACKGROUND: Phospholipid transfer protein (PLTP) is expressed by various cell types. In plasma, it is associated with high density lipoproteins (HDL). Elevated levels of PLTP in transgenic mice result in decreased HDL and increased atherosclerosis. PLTP is present in human atherosclerotic lesions, where it seems to be macrophage derived. The aim of the present study is to evaluate the atherogenic potential of macrophage derived PLTP. METHODS AND FINDINGS: Here we show that macrophages from human PLTP transgenic mice secrete active PLTP. Subsequently, we performed bone marrow transplantations using either wild type mice (PLTPwt/wt), hemizygous PLTP transgenic mice (huPLTPtg/wt) or homozygous PLTP transgenic mice (huPLTPtg/tg) as donors and low density lipoprotein receptor deficient mice (LDLR−/−) as acceptors, in order to establish the role of PLTP expressed by bone marrow derived cells in diet-induced atherogenesis. Atherosclerosis was increased in the huPLTPtg/wt→LDLR−/− mice (2.3-fold) and even further in the huPLTPtg/tg→LDLR−/− mice (4.5-fold) compared with the control PLTPwt/wt→LDLR−/− mice (both P<0.001). Plasma PLTP activity levels and non-HDL cholesterol were increased and HDL cholesterol decreased compared with controls (all P<0.01). PLTP was present in atherosclerotic plaques in the mice as demonstrated by immunohistochemistry and appears to co-localize with macrophages. Isolated macrophages from PLTP transgenic mice do not show differences in cholesterol efflux or in cytokine production. Lipopolysaccharide activation of macrophages results in increased production of PLTP. This effect was strongly amplified in PLTP transgenic macrophages. CONCLUSIONS: We conclude that PLTP expression by bone marrow derived cells results in atherogenic effects on plasma lipids, increased PLTP activity, high local PLTP protein levels in the atherosclerotic lesions and increased atherosclerotic lesion size. |
format | Text |
id | pubmed-2386265 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-23862652008-05-28 Elevated Expression of Phospholipid Transfer Protein in Bone Marrow Derived Cells Causes Atherosclerosis van Haperen, Rien Samyn, Hannelore Moerland, Matthijs van Gent, Teus Peeters, Marian Grosveld, Frank van Tol, Arie de Crom, Rini PLoS One Research Article BACKGROUND: Phospholipid transfer protein (PLTP) is expressed by various cell types. In plasma, it is associated with high density lipoproteins (HDL). Elevated levels of PLTP in transgenic mice result in decreased HDL and increased atherosclerosis. PLTP is present in human atherosclerotic lesions, where it seems to be macrophage derived. The aim of the present study is to evaluate the atherogenic potential of macrophage derived PLTP. METHODS AND FINDINGS: Here we show that macrophages from human PLTP transgenic mice secrete active PLTP. Subsequently, we performed bone marrow transplantations using either wild type mice (PLTPwt/wt), hemizygous PLTP transgenic mice (huPLTPtg/wt) or homozygous PLTP transgenic mice (huPLTPtg/tg) as donors and low density lipoprotein receptor deficient mice (LDLR−/−) as acceptors, in order to establish the role of PLTP expressed by bone marrow derived cells in diet-induced atherogenesis. Atherosclerosis was increased in the huPLTPtg/wt→LDLR−/− mice (2.3-fold) and even further in the huPLTPtg/tg→LDLR−/− mice (4.5-fold) compared with the control PLTPwt/wt→LDLR−/− mice (both P<0.001). Plasma PLTP activity levels and non-HDL cholesterol were increased and HDL cholesterol decreased compared with controls (all P<0.01). PLTP was present in atherosclerotic plaques in the mice as demonstrated by immunohistochemistry and appears to co-localize with macrophages. Isolated macrophages from PLTP transgenic mice do not show differences in cholesterol efflux or in cytokine production. Lipopolysaccharide activation of macrophages results in increased production of PLTP. This effect was strongly amplified in PLTP transgenic macrophages. CONCLUSIONS: We conclude that PLTP expression by bone marrow derived cells results in atherogenic effects on plasma lipids, increased PLTP activity, high local PLTP protein levels in the atherosclerotic lesions and increased atherosclerotic lesion size. Public Library of Science 2008-05-28 /pmc/articles/PMC2386265/ /pubmed/18509527 http://dx.doi.org/10.1371/journal.pone.0002255 Text en van Haperen et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article van Haperen, Rien Samyn, Hannelore Moerland, Matthijs van Gent, Teus Peeters, Marian Grosveld, Frank van Tol, Arie de Crom, Rini Elevated Expression of Phospholipid Transfer Protein in Bone Marrow Derived Cells Causes Atherosclerosis |
title | Elevated Expression of Phospholipid Transfer Protein in Bone Marrow Derived Cells Causes Atherosclerosis |
title_full | Elevated Expression of Phospholipid Transfer Protein in Bone Marrow Derived Cells Causes Atherosclerosis |
title_fullStr | Elevated Expression of Phospholipid Transfer Protein in Bone Marrow Derived Cells Causes Atherosclerosis |
title_full_unstemmed | Elevated Expression of Phospholipid Transfer Protein in Bone Marrow Derived Cells Causes Atherosclerosis |
title_short | Elevated Expression of Phospholipid Transfer Protein in Bone Marrow Derived Cells Causes Atherosclerosis |
title_sort | elevated expression of phospholipid transfer protein in bone marrow derived cells causes atherosclerosis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2386265/ https://www.ncbi.nlm.nih.gov/pubmed/18509527 http://dx.doi.org/10.1371/journal.pone.0002255 |
work_keys_str_mv | AT vanhaperenrien elevatedexpressionofphospholipidtransferproteininbonemarrowderivedcellscausesatherosclerosis AT samynhannelore elevatedexpressionofphospholipidtransferproteininbonemarrowderivedcellscausesatherosclerosis AT moerlandmatthijs elevatedexpressionofphospholipidtransferproteininbonemarrowderivedcellscausesatherosclerosis AT vangentteus elevatedexpressionofphospholipidtransferproteininbonemarrowderivedcellscausesatherosclerosis AT peetersmarian elevatedexpressionofphospholipidtransferproteininbonemarrowderivedcellscausesatherosclerosis AT grosveldfrank elevatedexpressionofphospholipidtransferproteininbonemarrowderivedcellscausesatherosclerosis AT vantolarie elevatedexpressionofphospholipidtransferproteininbonemarrowderivedcellscausesatherosclerosis AT decromrini elevatedexpressionofphospholipidtransferproteininbonemarrowderivedcellscausesatherosclerosis |